Hansen’s Disease: Still a Burden in Post Elimination Era
Despite the multidrug regimen, Hansen’s disease still remains a public health scourge. The present study aims to study the epidemiological and clinical trends of Hansen’s disease in a tertiary care center for a period of 1 year. A cross sectional study was carried out in the outpatient department of the institute for a period of 1 year from July 2020 to June 2021 and all leprosy cases were included in the study. The patients were examined thoroughly, and the diagnosis was done using WHO criteria. The nerves involved, lepra reactions were identified and disability was graded using WHO grading. Out of 62 patients, maximum number of patients (15 patients) were in the 21-30 years age group (24.2%). The most common type of leprosy was borderline lepromatous leprosy (32.25%) and nerve enlarged was the ulnar nerve (63.9%). As per WHO classification, 51(82.25%) cases were classified as MB and 11(17.7%) cases as PB. Among these 62 patients 25 ( 40%) were slit skin smear positive for AFB). A total of 18 patients (29.03%) presented with lepra reactions of which 10 presented with type 1 and 8 with type 2 reactions. A total of 25 patients (40.32%) presented with deformities which shows delayed diagnosis and inadequate timely treatment of disease and its complications. Our data shows that only 13% of cases reported within one year of noticing the symptoms. Community based studies are required to understand the reasons for such a situation in this area. Efforts must be made to prevent its spread, promote early detection, ensure proper treatment, and maintain patient follow-up.